Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician ’s Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

ConclusionsCilta-cel showed superior efficacy compared with physician ’s choice of treatment, making it a promising new treatment option for patients with triple-class exposed relapsed or refractory multiple myeloma.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research